Regenerative medicine has opened a new frontier in macular degeneration. Important steps have been made, and there are reasons to be optimistic about the future.
“Cautiously optimistic,” Demetrios G. Vavvas, MD, PhD, told Ocular Surgery News. “This path holds enormous promise, but the way is still long and we should avoid jumping to conclusions.”
With Michael J. Young, PhD, Vavvas is co-director of the Ocular Regenerative Medicine Institute of Massachusetts Eye and Ear, and part of a research group that has made significant advances in the understanding of stem cell
Uncategorized